Occidental Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.91M Buy
16,786
+796
+5% +$284K 0.7% 38
2025
Q4
$5.23M Buy
15,990
+491
+3% +$156K 0.63% 46
2025
Q3
$4.37M Buy
15,499
+338
+2% +$98K 0.55% 56
2025
Q2
$4.23M Buy
15,161
+1,174
+8% +$333K 0.58% 53
2025
Q1
$4.36M Buy
13,987
+1,014
+8% +$299K 0.66% 44
2024
Q4
$3.38M Buy
12,973
+1,074
+9% +$319K 0.53% 59
2024
Q3
$3.83M Buy
11,899
+645
+6% +$211K 0.62% 45
2024
Q2
$3.52M Buy
11,254
+677
+6% +$199K 0.62% 41
2024
Q1
$3.01M Buy
10,577
+5,692
+117% +$1.67M 0.56% 52
2023
Q4
$1.41M Buy
4,885
+3,371
+223% +$918K 0.29% 92
2023
Q3
$407K Buy
+1,514
New +$378K 0.09% 143

Other funds holding AMGN

Occidental Asset Management's AMGN Position: Q1 2026 in Review

Occidental Asset Management increased its Amgen (AMGN) stake by 5% in Q1 2026, buying an estimated $284K and bringing the position to 16,786 shares worth $5.91M. The position accounts for 0.7% of the portfolio, ranked #38.

Occidental Asset Management first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Occidental Asset Management held 16,786 shares of Amgen worth $5.91M as of Q1 2026.
  • Occidental Asset Management bought 796 Amgen shares in Q1 2026, an estimated $284K.
  • Amgen made up 0.7% of Occidental Asset Management's portfolio in Q1 2026, its #38 holding.
  • Occidental Asset Management first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Occidental Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.